Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Thrombosis
ADR ID BADD_A04284
ADR Hierarchy
24      Vascular disorders
24.01      Embolism and thrombosis
24.01.01      Non-site specific embolism and thrombosis
24.01.01.006      Thrombosis
Description Formation and development of a thrombus or blood clot in the blood vessel. [MeSH]
MedDRA Code 10043607
MeSH ID D013927
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Clot blood | Thrombosis | Thrombosis and thrombophlebitis of unspecified site | Thrombosis arm | Thrombosis leg | Thrombosis multiple | Thrombosis NOS | Obstructive thrombosis | Thrombotic vascular disease | Thrombus | Thromboses | Blood Clot | Blood Clots | Clot, Blood | Clots, Blood
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02241Tolcapone--
BADD_D02246Tolvaptan--
BADD_D02248Topotecan0.000112%
BADD_D02250Toremifene citrate0.000334%
BADD_D02254Tramadol--
BADD_D02261Tranexamic acid0.031175%
BADD_D02264Trastuzumab--
BADD_D02268Treprostinil--
BADD_D02270Tretinoin--
BADD_D02312Ulipristal--
BADD_D02319Urofollitropin--
BADD_D02321Ursodiol--
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000503%
BADD_D02337Varenicline--
BADD_D02338Varenicline tartrate--
BADD_D02363Vinorelbine--
BADD_D02364Vinorelbine tartrate--
BADD_D02373Warfarin0.001747%
BADD_D02375Water--
BADD_D02383Zidovudine0.004421%
BADD_D02392Zoledronic acid--
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
BADD_D02407Upadacitinib0.016516%
BADD_D02412Octreotide0.000559%
BADD_D02423Fondaparinux0.059701%
BADD_D02452Icatibant-
BADD_D02469Edoxaban0.000444%
BADD_D02470Nintedanib--
The 8th Page    First    Pre   8 9    Next   Last    Total 9 Pages
ADReCS-Target
ADR Term Drug Name Target